Nitrogen

Description

Nitrogen, Refrigerated Liquid is identified by the UN number 1977 and has a CAS number of 7727-37-9. It is classified as Nitrogen, NF and is commonly referred to as liquid nitrogen.

Uses and Indications

This drug is indicated for use in specific medical situations where the administration of nitrogen is deemed necessary. It is essential that this drug be administered only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of nitrogen. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the potential hazards associated with nitrogen administration, which may be contraindicated in certain circumstances. There are no reported teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Administration of nitrogen is associated with potential hazards and contraindications. It is imperative that nitrogen is used solely by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner must be well-versed in the indications, effects, dosages, methods, and frequency and duration of administration.

Nitrogen is to be administered via the respiratory route through inhalation. The active ingredient consists of nitrogen at a concentration of 990 mL in 1 L. Healthcare professionals should ensure that all safety protocols are followed during administration to mitigate risks associated with its use.

Contraindications

There are no specific contraindications listed for this product. However, it is essential to adhere to the following precautions to ensure safe handling and use:

• Handling should only occur after all safety precautions have been thoroughly read and understood.

• The product must be used and stored exclusively outdoors or in a well-ventilated area to minimize exposure to potentially hazardous conditions.

• Protection from sunlight is necessary when ambient temperatures exceed 52 degrees Celsius (125 degrees Fahrenheit) to prevent degradation or adverse reactions.

Warnings and Precautions

The use of this product necessitates careful consideration of the associated warnings and precautions to ensure safe administration and minimize risks to patients.

Cryogenic Hazards This product contains refrigerated gas, which poses a risk of cryogenic burns or injury. It is imperative to handle the gas with caution to prevent exposure that could lead to severe tissue damage. Additionally, the gas may displace oxygen in the environment, creating a risk of rapid suffocation.

Administration Supervision The administration of nitrogen is associated with potential hazards and may be contraindicated in certain situations. It is essential that this product is used solely by or under the supervision of a licensed practitioner who possesses experience in the use and administration of nitrogen. The practitioner must be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the hazards, contraindications, side effects, and necessary precautions.

Pressure-Related Risks The product contains gas under pressure, which may explode if subjected to heat. This characteristic necessitates strict adherence to storage and handling guidelines to prevent accidents. Furthermore, similar to the cryogenic risks, the gas may displace oxygen, leading to rapid suffocation in enclosed spaces.

First Aid Measures In the event of inhalation, it is crucial to remove the affected individual to fresh air and ensure they are comfortable for breathing. Medical advice or attention should be sought immediately. If the gas comes into contact with the skin, it is important to thaw any frosted areas using lukewarm water without rubbing the affected skin. Immediate medical advice or attention is also recommended in this scenario.

Healthcare professionals must remain vigilant and adhere to these warnings and precautions to ensure the safe use of this product.

Side Effects

Patients should be aware that inhalation of nitrogen gas may lead to serious adverse reactions, including asphyxiation due to oxygen displacement. This condition can result in rapid suffocation, which is a critical warning associated with the use of this substance.

It is essential for participants to understand the potential risks involved with exposure to nitrogen gas, particularly in environments where oxygen levels may be compromised. Monitoring and safety measures should be in place to prevent such occurrences.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Administration of nitrogen in pediatric patients may pose hazards or be contraindicated. It is essential that nitrogen is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner should be well-versed in the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The administration of nitrogen during pregnancy may pose potential risks and is considered hazardous or contraindicated. Pregnant patients should only receive nitrogen under the supervision of a licensed practitioner who is experienced in its use and administration. This practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions. Given the lack of specific data on fetal outcomes related to nitrogen exposure, healthcare professionals are advised to carefully weigh the benefits against the potential risks when considering its use in pregnant patients.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to lactating mothers, as the effects on breastfed infants are not established.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may arise from an overdose. Common symptoms may include, but are not limited to, severe drowsiness, confusion, respiratory distress, or any other unusual clinical manifestations.

Management of an overdose should be tailored to the individual patient and may involve supportive care, including monitoring vital signs and providing symptomatic treatment as necessary. In cases of significant overdose, consultation with a poison control center or a medical toxicologist is recommended to determine the most appropriate course of action.

It is crucial for healthcare professionals to educate patients about the importance of adhering to prescribed dosages and to provide guidance on what to do in the event of a suspected overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No specific postmarketing experience details are available in the extracted data. As such, there are no additional adverse events or rare case reports to summarize.

Patient Counseling

Healthcare providers should advise patients that the administration of nitrogen may pose hazards or be contraindicated. It is essential that nitrogen is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. Patients should be informed that the practitioner must be familiar with the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients must be instructed not to handle nitrogen until they have read and understood all safety precautions. It is crucial to use and store nitrogen only indoors or in a well-ventilated area. Providers should emphasize the importance of wearing appropriate protective equipment, including cold insulating gloves, a face shield, and eye protection during handling.

Healthcare providers should also inform patients about the necessity of using a backflow preventive device in the piping and the importance of closing the valve after each use and when the container is empty. Patients should be reminded to always keep the nitrogen container in an upright position.

Additionally, patients should be encouraged to read and follow the Safety Data Sheet (SDS) prior to use. In the event of an emergency, providers should instruct patients on first aid measures: if nitrogen is inhaled, they should be removed to fresh air and kept comfortable for breathing, and medical advice or attention should be sought. If nitrogen comes into contact with the skin, patients should thaw any frosted areas with lukewarm water without rubbing the affected area and seek immediate medical advice or attention.

Storage and Handling

The product is supplied in a container that must be kept in an upright position at all times. It is essential to use and store the product indoors or in a well-ventilated area. For compressed nitrogen, the product should be used and stored outdoors or in a well-ventilated space.

To ensure safety, the valve should be closed after each use and when the container is empty. Additionally, the product must be protected from sunlight when the ambient temperature exceeds 52 degrees Celsius (125 degrees Fahrenheit). It is recommended to utilize a backflow preventive device in the piping to maintain safety and integrity.

Prior to use, it is crucial to read and follow the Safety Data Sheet (SDS) for comprehensive safety information and handling instructions.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. Clinicians should be aware that the administration of nitrogen may pose hazards or be contraindicated. It is essential that this medication is used only by or under the supervision of a licensed practitioner who has experience with nitrogen administration. This practitioner should be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by Mississippi Welders Supply Company, Inc.. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)